1. Daily life physical activity in patients with chronic stage IV sarcoidosis: A multicenter cohort study
- Author
-
François J. Lhuissier, Sandrine Stelianides, Sarah Froidure, Lidwine Wemeau, Maeva Kyheng, Benoit Wallaert, and Jean Marie Grosbois
- Subjects
Vital capacity ,medicine.medical_specialty ,business.industry ,VO2 max ,General Medicine ,daily life physical activity ,anxiety ,Confidence interval ,Pulmonary function testing ,aerobic capacity ,pulmonary function test ,Interquartile range ,Internal medicine ,depression ,medicine ,fatigue ,Lung volumes ,sarcoidosis ,Prospective cohort study ,business ,Respiratory Medicine ,Body mass index ,Research Articles ,Research Article - Abstract
Background and objectives Little is known about the consequences of chronic sarcoidosis on daily life physical activity (DLPA). The aim of this prospective study was to measure DLPA in patients with chronic sarcoidosis and to determine its relationship to clinical and functional parameters. Methods Fifty‐three patients with chronic sarcoidosis and 28 healthy control subjects were enrolled in this multicenter prospective study. Two markers of DLPA (number of steps walked per day [SPD]) and total daily energy expenditure (TEE) were assessed for five consecutive days with a physical activity monitor. Pulmonary function, aerobic capacity (maximal oxygen uptake [VO2max]), exercise capacity (6‐min walk test [6MWT]), and quality of life (self‐reported questionnaires) were also evaluated. Comparisons of DLPA parameters between the two groups were performed using an analysis of covariance adjusted for age, sex, and body mass index (BMI). Relationships between DLPA parameters and patient characteristics were assessed in multivariable linear regression models. Results Patients with sarcoidosis walked significantly fewer SPD than did the control subjects (6395 ± 4119 and 11 817 ± 3600, respectively; P
- Published
- 2019